4/28/2022Sales Expenditures of Listed Chinese Pharma Companies Sharply Up Again...

4/28/2022SMEI Revises Down Chinese Pharma Industry Growth Projection in 2022

4/28/2022Sanofi Reports Q1/2022 Performance, Witnessing 13.4% Growth in China

4/27/2022Xbiome Acquires Clinical-Stage Program Targeting Ulcerative Colitis

4/26/2022AstraZeneca Remain Bullish on Long-term Development in China

4/26/2022NMPA and Chinese Customs Announce Addition of Zhongshan City's Zhongsh...

4/26/2022AstraZeneca Plans Innovation Center for Traditional Chinese Medicines

4/26/2022China Clears Homegrown PD-1 Inhibitors for Solid Tumors (PharmaDJ's Ch...

4/25/2022AstraZeneca Withdraws Suits After SPC Sidesteps Review of "Reverse Pay...

4/22/2022Bayer Seeks Expanded Use of Prostate Cancer Drug Nubeqa in China

4/22/2022Recent Executive Moves

4/21/2022ATUM Accelerates Entry of Bioengineering Solutions into China

4/20/2022Joseph Romanelli Returns to Merck to Lead Human Health International A...

4/20/2022I-Mab Reportedly Weighing Options Including Sale: Bloomberg

4/20/2022PharmaDJ's China Biotech Fundraising Tracker: March 2022

4/20/2022China Commercial Health Insurance Opportunities

4/19/202234 HK-Listed Chinese Biopharma Firms Saw Sharp Revenue Growth in 2021 ...

4/18/2022VectorBuilder to Build $500M Gene Therapy Manufacturing Facility in Ch...

4/16/2022Opportunities and Challenges in China for Developing Oncology Drugs fo...

4/15/2022NMPA Issues the Guidelines for Pharmacovigilance Inspections

4/14/2022PhIIC: Chinese Retail Biologics Sales Led by Anti-tumor Drugs in 2021

4/13/2022China Meheco to Distribute Ascletis's Ritonavir Tablets in Mainland Ch...

4/12/2022Chinese Pharma Foreign Trade Up 1.9% in 2021 with Sharply Surging West...

4/12/2022NMPA Issues the Measures for Drug Annual Reports

4/11/2022Decentralized CRO Science 37 Expands in the Asia-Pacific including Chi...

4/11/2022Clinical Development Strategies for Western Biotech Companies in China...

4/10/2022Market Segmentation Snapshot of Chinese Retail Drug Market 2019-2021

4/10/2022Chinese Pharma Profits Fell Sharply in the First Two Months of 2022

4/8/2022Recent Executive Moves

4/8/2022China Views Pay-For-Delay Deal as Antitrust Offence, Lawyer Cautions (...

Page:68/356 Total number of articles:10671: [First][<<] [66] [67] [68] [69] [70] [>>] [End]